Search
State ActionCCAGW Urges Hawaii Senate Committee on Ways and Means to Oppose SB 974
SB 974 will fail to achieve its objective of protecting consumer privacy.
State ActionCCAGW Urges Alaska Senate Health and Social Services Committee to Support SB 8
SB 8 would repeal Alaska's outdated certificate-of-need laws.
The WasteWatcherPatients Pay the Ultimate Price for Price Controls
Price controls on pharmaceuticals distort the medical marketplace and will not lower drug prices.
The WasteWatcherHochul Doubles Down on Green Bad Deal Policies
Governor Hochul's budget proposal doubles down on ill-advised "Green New Deal" policies.
State ActionCCAGW Urges Minnesota House Commerce Committee to Oppose HF 294
HF 294 will create price controls that distort the medical marketplace and impose burdensome restrictions that stifle innovation.
The WasteWatcherCalifornia's Budget Debacle
Poor planning has put California in a perilous financial position.
The WasteWatcherHouse Committees Hold Oversight Hearings on COVID-19 Relief Fraud
Long overdue oversight hearings were finally held in the House of Representatives.
Letters to OfficialsCCAGW Urges Senate Judiciary Committee to Oppose S. 150
S. 150 would give the Federal Trade Commission redundant and unnecessary powers.
State ActionCCAGW Urges Minnesota Senate Commerce and Consumer Protection Committee to Oppose SF 168
SF 168 would impose price controls on prescription drugs through the establishment of the Prescription Drug Affordability Review Board.
State ActionCCAGW Urges Hawaii Senate Commerce and Consumer Protection Committee to Oppose SB 974
SB 974 will fail to achieve its objective of protecting consumer privacy.
State ActionCCAGW Urges Missouri Senate Health and Welfare Committee to Support SB 204
SB 204 would repeal Missouri's outdated certificate-of-need laws.
State ActionCCAGW Urges Minnesota House State and Local Government Finance and Policy Committee to Oppose HF 17
HF 17 would impose price controls on prescription drugs through the establishment of the Prescription Drug Affordability Review Board.
